Many patients have the misconception that once kidney cancer is diagnosed, it is a “death sentence” and that all treatment will only prolong life, not cure it. In fact, such an understanding is very wrong. The company’s main goal is to provide a comprehensive range of services to the public.
In layman’s terms, “early kidney cancer” is what doctors often call “limited kidney cancer. In practice, more than half of all kidney cancer patients have limited kidney cancer. The first choice of treatment for these patients is surgery, and most can be cured.
- For patients with early-stage kidney cancer who are physically able to tolerate surgery, the preferred treatment option is surgery. When the tumor is small and well located, partial nephrectomy is often used. In this procedure, the patient does not need to have the entire kidney removed and can preserve as much kidney function as possible while ensuring complete tumor removal.
- For early-stage renal tumors that are large or poorly located, urologic oncologists often choose radical nephrectomy, which removes the entire kidney that has the tumor. Because both kidneys have a certain degree of compensatory capacity, after removing one kidney, the remaining kidney function can also be fully compensated, maintaining normal kidney function in humans.
Patients with early-stage kidney cancer treated with surgery rarely have recurrence or metastasis after surgery, and the vast majority of patients do not have recurrence or metastasis after surgery and are “cured”. For patients who are not physically able to tolerate surgery, effective treatment modalities such as active monitoring and radiofrequency therapy can also greatly extend survival and help improve quality of life.